Scaffold Free 3D Cell Culture Market Size

Scaffold Free 3D Cell Culture Market size was over USD 68.14 billion in 2023 and is expected to exceed USD 270.87 billion by 2036, witnessing over 11.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of scaffold free 3D cell culture is evaluated at USD 74.25 billion. The growth of the market can be attributed to the growing emphasis on developing alternatives to animal testing, and rising focus on personalized medicine around the world. In the United States alone, a total of 286 personalized medicines were available in 2020. In addition, the investments in these medicines in the country grew by 53% in the years 2011-2015. Along with these, increasing incidences of chronic diseases, and upsurge in funding for cell-based research globally are also expected to drive market growth in the forthcoming years. In 2019, there were more than 15 million deaths from all types of cardiovascular diseases across the globe. Also, cancer and respiratory diseases caused about 9 million and 4 million deaths that same year. Furthermore, escalating investments in the healthcare sector, and growth in the number of cases of infectious diseases, such as H1N1 and influenza, are projected to offer ample growth opportunities to the market in the near future.